145 related articles for article (PubMed ID: 17464247)
1. Utilization of chromatin remodeling agents for lung cancer therapy.
Schrump DS; Hong JA; Nguyen DM
Cancer J; 2007; 13(1):56-64. PubMed ID: 17464247
[TBL] [Abstract][Full Text] [Related]
2. Genomic surgery for lung cancer.
Schrump DS
J Surg Res; 2004 Mar; 117(1):107-13. PubMed ID: 15013720
[TBL] [Abstract][Full Text] [Related]
3. Targeting the epigenome for the treatment of thoracic malignancies.
Schrump DS; Nguyen DM
Thorac Surg Clin; 2006 Nov; 16(4):367-77, vi. PubMed ID: 17240824
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches on epigenetics.
Papait R; Monti E; Bonapace IM
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
Schrump DS; Fischette MR; Nguyen DM; Zhao M; Li X; Kunst TF; Hancox A; Hong JA; Chen GA; Pishchik V; Figg WD; Murgo AJ; Steinberg SM
Clin Cancer Res; 2006 Oct; 12(19):5777-85. PubMed ID: 17020984
[TBL] [Abstract][Full Text] [Related]
7. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
Cowan LA; Talwar S; Yang AS
Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
[TBL] [Abstract][Full Text] [Related]
8. DNA methyltransferase inhibitors for cancer therapy.
Brueckner B; Kuck D; Lyko F
Cancer J; 2007; 13(1):17-22. PubMed ID: 17464242
[TBL] [Abstract][Full Text] [Related]
9. The dynamic epigenome and its implications in toxicology.
Szyf M
Toxicol Sci; 2007 Nov; 100(1):7-23. PubMed ID: 17675334
[TBL] [Abstract][Full Text] [Related]
10. Targeting the epigenome for the treatment and prevention of lung cancer.
Schrump DS; Nguyen DM
Semin Oncol; 2005 Oct; 32(5):488-502. PubMed ID: 16210090
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
12. Potential epigenetic therapeutics for atherosclerosis treatment.
Nicorescu I; Dallinga GM; de Winther MPJ; Stroes ESG; Bahjat M
Atherosclerosis; 2019 Feb; 281():189-197. PubMed ID: 30340764
[TBL] [Abstract][Full Text] [Related]
13. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modification boosts ovarian cancer vaccination.
Benmaamar R
Lancet Oncol; 2014 Feb; 15(2):e55. PubMed ID: 24627909
[No Abstract] [Full Text] [Related]
15. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
16. Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway.
Widodo N; Deocaris CC; Kaur K; Hasan K; Yaguchi T; Yamasaki K; Sugihara T; Ishii T; Wadhwa R; Kaul SC
J Gerontol A Biol Sci Med Sci; 2007 Mar; 62(3):246-55. PubMed ID: 17389721
[TBL] [Abstract][Full Text] [Related]
17. ANKRD18A as a novel epigenetic regulation gene in lung cancer.
Liu WB; Han F; Jiang X; Yang LJ; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):180-5. PubMed ID: 23131552
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and gene silencing in cancer.
Baylin SB
Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
[TBL] [Abstract][Full Text] [Related]
19. [Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors].
Daskalakis M; Blagitko-Dorfs N; Hackanson B; Lübbert M
Pharm Unserer Zeit; 2010 May; 39(3):217-27. PubMed ID: 20425776
[No Abstract] [Full Text] [Related]
20. Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists.
Kusakabe M; Watanabe K; Emoto N; Aki N; Kage H; Nagase T; Nakajima J; Yatomi Y; Ohishi N; Takai D
Biochem Biophys Res Commun; 2009 Dec; 390(4):1283-7. PubMed ID: 19878646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]